Diffusion Pharmaceuticals... (DFFN)
NASDAQ: DFFN
· Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM
Diffusion Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -5.3M | -8.99M | -5.4M | -3M | -2.67M | 2.29B | 4.27B | -10.1M | 2.92M | 4.25B | 4.55B | -3.47M | 12.69M | -3.83M | -4.68M |
Interest Income | 408.99K | 1.54M | 646.17K | 678.44K | 47.67K | 179.46K | 173.9K | 172.85K | 124.71K | 55.38K | 27.81K | -8.87K | 50.71K | 55.23K | 40.42K |
Pretax Income | -4.89M | -12.24M | -4.75M | -2.32M | 2.15M | -2.11M | -4.09M | -4.08M | -2.8M | -4.19M | -4.53M | -3.47M | -12.64M | -3.78M | -4.64M |
Net Income | -4.89M | 8.35B | -4.75M | -2.32M | 2.15M | -2.11M | -8.36B | 2.03M | -8.39M | -4.19M | -4.53M | -3.47M | -12.2M | -3.78M | -4.64M |
Selling & General & Admin | 2.38M | 1.58M | 2.21M | 2.51M | 2.41M | 2.22M | 2.96M | 2.34M | 2.13M | 2.14M | 2.13M | 1.94M | 1.93M | 1.84M | 1.74M |
Research & Development | 4.84M | 15.63M | 5.13M | 3.77M | 1.79M | 72.19K | 1.31M | 1.9M | 798.25K | 2.11M | 2.43M | 1.5M | 2.11M | 1.97M | 2.92M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 7.22M | 17.2M | 7.34M | 6.28M | 4.2M | 2.29M | 4.27M | 4.25M | 2.92M | 4.25M | 4.55M | 3.47M | 4.05M | 3.83M | 4.68M |
Interest Expense | n/a | -8.36B | n/a | n/a | n/a | n/a | 8.36B | n/a | 124.71K | n/a | n/a | -146K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 17.2M | n/a | n/a | 4.2M | 2.29M | 4.27M | 4.25M | 2.92M | 4.25M | 4.55M | 3.47M | 4.05M | 3.83M | 4.68M |
Income Tax Expense | n/a | -8.36B | n/a | n/a | n/a | n/a | 8.36B | -6.1M | 5.6M | n/a | n/a | n/a | -444K | n/a | n/a |
Shares Outstanding (Basic) | 8.7M | 8.07M | 8.7M | 8.7M | 3.77M | 1.36M | 2.04M | 2.04M | 2.04M | 1.36M | 2.04M | 97.63M | 2.04M | 2.04M | 1.65M |
Shares Outstanding (Diluted) | 8.7M | 8.07M | 8.7M | 8.7M | 3.77M | 1.36M | 2.04B | 1.36M | 2.04M | 1.36M | 2.04M | 97.63M | 2.04M | 2.04M | 1.65M |
EPS (Basic) | -0.56 | 1.03K | -0.55 | -0.27 | 0.57 | -1.55 | -6.15K | 1.49 | -6.18 | -3.08 | -2.22 | -0.04 | -5.99 | -1.85 | -2.81 |
EPS (Diluted) | -0.56 | 1.03K | -0.55 | -0.27 | 0.57 | -1.55 | -6.15K | 1.49 | -6.18 | -3.08 | -2.22 | -0.04 | -5.99 | -1.85 | -2.81 |
EBITDA | -5.3M | -8.37B | -5.4M | -3M | -2.67M | -2.29M | 4.27B | -4.25M | -2.92M | -4.25M | -4.55M | -3.44M | 4.6M | -3.81M | -4.66M |
EBIT | n/a | -12.63B | n/a | n/a | n/a | n/a | 12.63B | 7.42M | -2.67M | n/a | n/a | -3.62M | n/a | -3.83M | -4.68M |
Depreciation & Amortization | n/a | -82.5K | n/a | n/a | -39.59K | 122.08K | n/a | 5.64M | -5.85M | 86.06K | -13.55M | 26.11K | 19.1K | 23.75K | 24.45K |